For two decades, employer health benefits strategy has been shaped by a guiding principle: give members information and financial responsibility and they will make better decisions. That concept reshaped benefit design across the country, but it didn't move the cost trend line.
The original promise of healthcare consumerism, that informed, supported patients can make better decisions and drive better outcomes, was never the problem. The problem was the execution. Cost-shifting was sold as consumer engagement and it wasn’t. A high deductible is not a decision-support tool. Exposing members to first-dollar costs is not the same as equipping them to make better choices. Real consumer engagement that drives meaningful savings requires three things working together: validated quality analytics, real navigation support and financial incentives aligned to high-value care. For two decades, employers were sold the third lever — financial exposure — without the first two.
The verdict on cost-shifting
High-deductible health plans (HDHPs) cover roughly 58% of privately insured Americans and have become the default architecture of employer-sponsored coverage. They were sold on the theory that exposing members to first-dollar costs would make them prudent purchasers. HDHPs have reduced overall utilization, which is a feature for low-risk populations: fewer unnecessary visits, lower premiums and the ability to build savings through tax-advantaged accounts. But the research shows a consistent and concerning pattern on the margins: HDHP enrollment is associated with reduced use of evidence-based care, lower medication adherence for chronic disease and higher rates of preventable acute events. A 2023 cohort study of 245,000 adults with diabetes found that among those who switched to an HDHP, emergency department visits for severe hyperglycemia increased by 25% and a study of 343,000 patients showed statistically significant reductions in guideline-concordant care across multiple chronic conditions after HDHP enrollment. A systematic review of diabetes care found that while HDHPs reduced spending, they also limited high-value care and medication adherence — outcomes that carry their own downstream costs.
This isn’t a story of consumer failure. It’s a story of a cost-shifting mechanism that reduced both necessary and unnecessary utilization, suppressing care for those that need it the most.
Health Savings Accounts offer real value — a triple tax advantage, portability and the ability to build a long-term reserve for medical expenses. For higher-income, healthy accountholders with financial flexibility, they work largely as intended. But the Employee Benefit Research Institute (EBRI) data shows that for many, HSAs aren't functioning as the wealth-building, decision-shaping benefit they were designed to be. The average balance is $4,747 — modest against an out-of-pocket maximum of $8,300 for individual HDHP coverage — and that figure is skewed upward by older, higher-income accountholders. More than half take a distribution each year, only 15% invest any portion of their balance and average employee contributions sit nearly $1,000 below the statutory maximum for individuals and more than $4,500 below for families. For most accountholders, the HSA functions as a slightly tax-advantaged account for current medical bills — useful, but not the behavior-change lever it was intended to be.
Price transparency has been a meaningful step forward. Federal rules now require hospitals and health plans to disclose negotiated rates and that infrastructure is reshaping what’s possible. But price transparency alone, without navigation support and quality data, has not changed how most members make care decisions. Amongst insured populations, multiple studies show single-digit usage rates of price transparency tools. Research also shows that access to price information doesn’t reliably translate into cost-conscious behavior, proving that while price-aware patients sometimes selected lower-cost services, those individual choices did not reduce aggregate healthcare spending.
Three of the largest behavioral interventions in employer health benefits —high deductibles, tax-advantaged accounts and price transparency — were designed to encourage more consumer-driven decision-making. However, these interventions on their own have not meaningfully changed the trajectory of healthcare costs or consistently steered members to higher-value care.
Shift the decision
Evaluating whether an orthopedist is in the top quartile for outcomes or whether a physician-ordered MRI is clinically necessary is not a reasonable expectation to place on a patient. They shouldn’t have to read a quality measure and translate it into a referral decision while they’re sitting on an exam table in a paper gown. These are highly complex clinical judgments that many patients don’t have the information, time or context to evaluate on their own. Asking patients to navigate these decisions alone places too much responsibility on individuals without giving them the clinical context, guidance or support needed to make confident choices.
The clinical variation that drives costs lives inside decisions made by physicians — referrals, imaging orders, surgical recommendations, site-of-service selections, etc. Choices made by providers influence roughly 80% of the healthcare dollar. No amount of member-side cost exposure changes how those decisions are made. That’s why effective consumer engagement cannot rely on cost exposure alone. It requires clinically validated guidance embedded into how care decisions are made.
Case for quality-driven design
The next generation of plan design is focused on redesigning the system so patients are supported by actionable information and better-aligned financial features. The goal is not to teach members to behave like sophisticated buyers in a market they can’t navigate. The goal is to align financial levers so that high-quality care becomes the default.
That is why quality-driven plan design is gaining traction with employers and health plans. The market is moving and the models that solve for clinical variation, rather than re-packaging cost-shifting, will deliver the savings employers actually need.
A quality-driven health plan doesn’t require rebuilding networks, switching carriers or asking members to become amateur clinicians. It uses validated provider performance data — peer-reviewed, claims-based and risk-adjusted — to identify high-performing physicians already inside an existing network. It puts the information where it belongs: embedded in the plan design itself, supported by guidance and reinforced by aligned financial incentives.
New alternatives will be defined by whether they take the decision-making burden off members who were never equipped to carry it. The next generation of plan design succeeds not by abandoning consumer engagement, but by supporting it differently — pairing incentives with trusted guidance, validated quality data and navigation that help patients reach the right care more easily. Healthcare is not as simple as shopping for a car or a flight. Consumerism has moved the needle. What unlocks its full potential is pairing it with what was always missing: validated quality data and incentives aligned to high-value care.
